SLC1A5 and pancreatic neoplasm: Pancreatic cancer cell‐derived EVs upregulated SLC1A5 expression in PSCs, with a more pronounced effect in GEM‐resistant cells that was not altered by the addition of Asn alone (Figure S3D–E, Supporting Information).